Duvyzat 8.86 mg/mL oral suspension Images
Generic Name: givinostat
This medication has been identified as Duvyzat 8.86 mg/mL oral suspension. It is supplied by ITF Therapeutics, LLC.
Duvyzat is used in the treatment of Duchenne Muscular Dystrophy and belongs to the drug class histone deacetylase inhibitors. Duvyzat 8.86 mg/mL oral suspension is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication

Duvyzat
- Generic Name
- givinostat
- Strength
- 8.86 mg/mL oral suspension
- Availability
- Prescription only
- Drug Class
- Histone deacetylase inhibitors
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- ITF Therapeutics, LLC
- Manufacturer
- Italfarmaco S.A.
- National Drug Code (NDC)
- 11797-0110
See also:
Agamree
Agamree (vamorolone) is an FDA-approved treatment for Duchenne muscular dystrophy (DMD) to improve ...
Emflaza
Emflaza (deflazacort) is a corticosteroid medication used to treat a rare genetic disorder called ...
Viltepso
Viltepso (viltolarsen) is used for the treatment of Duchenne muscular dystrophy (DMD) treatable ...
Amondys 45
Amondys 45 (casimersen) is used to treat Duchenne muscular dystrophy (DMD) with a genetic mutation ...
Elevidys
Elevidys is a gene therapy for Duchenne muscular dystrophy, that is given as a one-time infusion ...
Vyondys 53
Vyondys 53 is used for Duchenne muscular dystrophy (DMD) in children and young adults with a ...
Exondys 51
Exondys 51 is used for Duchenne Muscular Dystrophy (DMD) in children and young adults with a ...
Golodirsen
Golodirsen is used to treat Duchenne muscular dystrophy (DMD) in children and young adults with a ...
Eteplirsen
Eteplirsen is used for Duchenne Muscular Dystrophy (DMD) in children and young adults with a gene ...
More about Duvyzat (givinostat)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: histone deacetylase inhibitors
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.